Clinical Trial Update: HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating HLA haploidentical bone marrow transplant in patients with severe sickle cell dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HLA haploidentical bone marrow transplant

Snippet

Sponsor: Centre Hospitalier Intercommunal Creteil | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED